Pages that link to "Item:Q2679319"
From MaRDI portal
The following pages link to Optimizing combination therapy in a murine model of HER2+ breast cancer (Q2679319):
Displaying 8 items.
- The optimal dose of CAF regimen in adjuvant chemotherapy for breast cancer patients at stage IIB (Q933282) (← links)
- Model selection for assessing the effects of doxorubicin on triple-negative breast cancer cell lines (Q2105797) (← links)
- Mathematical model of triple-negative breast cancer in response to combination chemotherapies (Q2111185) (← links)
- Mathematical modelling of trastuzumab-induced immune response in an in vivo murine model of HER2+ breast cancer (Q5860550) (← links)
- On the analysis of a mathematical model of CAR-T cell therapy for glioblastoma: insights from a mathematical model (Q6069347) (← links)
- Investigating tumor-host response dynamics in preclinical immunotherapy experiments using a stepwise mathematical modeling strategy (Q6154133) (← links)
- Bridging scales: a hybrid model to simulate vascular tumor growth and treatment response (Q6201151) (← links)
- Modeling of mouse experiments suggests that optimal anti-hormonal treatment for breast cancer is diet-dependent (Q6204205) (← links)